|
|
|
|
|
Considerations in Outsourced Vaccine Manufacturing
|
|
|
| By
Amy Ritter, PhD
|
|
|
|
Marco Chacon of Paragon Bioservices discusses the challenges associated with outsourced vaccine manufacturing.
|
|
|
|
Considerations in Vaccine Packaging and Delivery Systems
|
|
|
| By
Amy Ritter, PhD
|
|
|
|
Glenn Thorpe of West Pharmaceutical Services gives an update on packaging and delivery methods for vaccines.
|
|
|
|
Vaccine Packaging at the Clinical Interface of Vaccine, Healthcare Worker, and Patient
|
|
|
| By
Brian Lynch
,
Philip Song
|
|
|
|
Packaging vaccines using prefilled syringes can increase dosing efficiency, reduce costs, and improve patient safety. This article is part of a special section on vaccines.
|
|
|
|
A Manufacturing-Capacity Sharing Model
|
|
|
| By
Patricia Van Arnum
|
|
|
|
The manufacturing capacity-sharing model between Merck and MedImmune ushers in a new paradigm of "co-opetition."
|
|
|
|
Key Considerations in Biosimilars Development
|
|
|
| By
Raymond Donninger
,
Joe Bower
,
Raymond Kaiser
,
Sian Estdale
,
John Carlsen
|
|
|
|
Understanding opportunities and challenges across all major phases of development.
|
|
|
|
Correlating Product Lifecycle and Manufacturing Site Characteristics with Product Deviations
|
|
|
| By
Reuben D. Domike
,
Jeffrey T. Macher
,
Paul W. Barone
,
Stacy L. Springs
,
Anthony J. Sinskey
,
Scott Stern
|
|
|
|
MIT survey results address product and site characteristics that statistically correlate with quality performance.
|
|
|
|
Bringing Innovation to Neglected Disease R&D
|
|
|
| By
BIO Ventures for Global Health
,
Biotechnology Industry Organization
|
|
|
|
A new report highlights the industry's contributions to neglected diseases and calls for further collaboration.
|
|
|
|
A 25-Year Retrospective on Cleanroom Management
|
|
|
| By
Anne Marie Dixon
|
|
|
|
Anne Marie Dixon of Cleanroom Management Associates, gives us an update on her 1988 article, "Clean Room Management."
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discovery Pipeline: Nanoparticles for Targeted Delivery
|
|
|
| By
Amy Ritter, PhD
|
|
|
|
Recently published research demonstrates how nanoparticles can be used to overcome hurdles in localized drug delivery.
|
|
|
|
Report from India
|
|
|
| By
Jane Wan
|
|
|
|
India has enforced stricter patent laws compared to other countries. For a drug to be patentable in India, the invention has to be novel, inventive, and industrially applicable.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
